Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus Cream 1% in Head and Neck Atopic Dermatitis
NCT00121316Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD) (2 arms), sponsored by Novartis. Primary endpoint: Percentage of patients with facial Investigator's Global Assessment (IGA) score of 0 or 1. Started Oct 2004; status: completed.
02
Drugs
Pimecrolimus vehicle + topical corticosteroid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00121316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00121316.